Abstract
Rats were trained to shuttle between two selected ("ON") arms of a Y maze, to obtain electrical stimulation of the medial forebrain bundle. Each shuttle response was rewarded with a brief pulse train. Repetitive entries into the same "ON" arm were not rewarded, nor were entries made into the third ("OFF") arm. Every 67s, stimulation was made available from a different pair of arms. Test sessions lasted for 80 min, beginning immediately after SC injection. Undrugged subjects responded faster, and with a greater proportion of rewarded responses, the higher the stimulation current. In non-tolerant rats, nicotine (0-0.4 mg/kg) depressed responding and induced ataxia shortly after injection; from 40 min, nicotine increased low rates of responding but decreased high rates. All these effects were dose-dependent. Mecamylamine (2.0 mg/kg) prevented the initial depressant action. With repeated daily injections of nicotine (0.4 mg/kg), a marked stimulant action emerged which replaced the initial depressant action, and this was dose-dependent. However, responding was increased by nicotine even when brain stimulation was not available ("time-out"). In contrast, an additional "rate-free" index based on discrimination showed that nicotine did...Continue Reading
References
Mar 1, 1979·Archives of General Psychiatry·C KornetskyJ O Jacobson
Jul 1, 1973·Pharmacology, Biochemistry, and Behavior·E F Domino, M P Lutz
Sep 1, 1972·British Journal of Pharmacology·C F Morrison, J A Stephenson
Jan 1, 1971·Psychopharmacologia·P A Björkstrand, I Dureman
Sep 20, 1968·Psychopharmacologia·C F Morrison, P N Lee
May 1, 1967·International Journal of Neuropharmacology·C F Morrison
Feb 1, 1983·British Journal of Pharmacology·P B Clarke, R Kumar
Oct 30, 1981·Science·S R GoldbergD M Goldberg
Aug 3, 1957·Lancet·G BENNETTE ZAIMIS
Feb 1, 1958·Postgraduate Medical Journal·R COX
Citations
Jan 1, 1984·Psychopharmacology·P B Clarke, R Kumar
Jan 1, 1989·Psychopharmacology·J P DruhanA G Phillips
Oct 22, 2005·Psychopharmacology·Nadia ChaudhriAlan F Sved
Oct 1, 1985·Biochemical Pharmacology·J M Shallom, S S Katyare
Oct 15, 1989·Biochemical Pharmacology·B R MartinT J Martin
Jul 1, 1989·Pharmacology, Biochemistry, and Behavior·W A CorrigallK M Coen
Apr 1, 1992·Pharmacology, Biochemistry, and Behavior·D Huston-Lyons, C Kornetsky
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·G Tanda, S R Goldberg
Apr 20, 1999·Pharmacology, Biochemistry, and Behavior·A M Montgomery, A J Grottick
Apr 20, 1999·Pharmacology, Biochemistry, and Behavior·S S WatkinsA Markou
Nov 20, 1998·Behavioural Brain Research·M A BozarthR KuoLee
Jun 24, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiu LiuRussell E Poland
May 7, 2004·Addiction·Thomas Eissenberg
Nov 1, 1988·Angiology·D BernardiA Ieri
Oct 1, 1984·British Journal of Pharmacology·P B Clarke
May 1, 1984·British Journal of Pharmacology·P B Clarke, R Kumar
Nov 1, 1983·British Journal of Pharmacology·P B Clarke, R Kumar
Aug 1, 1985·British Journal of Pharmacology·P B ClarkeL R Skirboll
Nov 13, 2017·Psychopharmacology·Annie Constantin, Paul B S Clarke